ArticleOncology reports2024

SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy.

Gongjie Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.